Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《China Health Industry》 2011-Z6
Add to Favorite Get Latest Update

Aescin in Combination with Aspirin to Prevent Recurrence of Cerebral Infarction Observation

Huang Yan Sichuan Province??Qionglai City Medical Center Hospital,Sichuan 611530,China  
Objective aescin combination with aspirin for prevention of cerebral infarction recurrence of clinical efficacy.Methods 80 patients with cerebral infarction were randomly divided into treatment group and control group,40 patients in each group.Both groups were given the condition of patients blood pressure,glucose,cholesterol,and so conventional therapy,the treatment group were:β-PNS 0.5g/d,3 times a day orally,enteric-coated aspirin 75mg/d,each Day 1.The treatment lasted 15 days.Before and after treatment the clinical efficacy and recurrence.Results There were no bleeding during the treatment side effects and adverse reactions.The effective rate in treatment group 92.5%,control group was 72.5%,total effective rate between the two groups,treatment group was significantly better than the control group (P0.05). And the treatment group,neurological deficit scores significantly decreased after treatment was significantly lower than the control group,the difference was significant (P0.05).And follow-up 2~3 years,the treatment group the recurrence rate was 5% in the control group, the recurrence rate was 20%,the treatment group,the recurrence rate was significantly lower than the control group (P0.05).Conclusion aescin treatment of cerebral infarction is effective in combination with aspirin, no significant adverse reactions,relapse rate,widely promoted for primary hospital.
【CateGory Index】: R743.3
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved